GGrantIndex
← Leaderboards

University Of California, San Francisco

San Francisco, CA

Compare ↔
$12,410,908,380
Total funding
9,119
Grants

Funding over time

peak $985.9M · FY2006–25
$1B$750M$500M$250M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,132,866,751 · 8974
CDC$281,902,598 · 65
AHRQ$71,279,183 · 75
FDA$61,947,780 · 13
SAMHSA$0 · 8

By mechanism

R01$5,349,321,849 · 2451
U01$1,142,176,232 · 229
P01$499,695,869 · 463
P30$435,503,147 · 402
T32$386,843,090 · 90
R35$322,915,477 · 85

Investigators at University Of California, San Francisco

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Andrew Chris Yang$4,713,0573 gr2Javier Caravaca$4,172,2052 gr3Xu Chen$3,581,2852 gr4David A Ziegler$3,231,6663 gr5Amar Nijagal$3,176,6801 gr6Jennifer M. Rosenbluth$3,109,4072 gr7Corinne H. Rocca$2,901,8812 gr8Melanie A Morrison$2,861,6762 gr

Emerging Leaders

6–10 yrs in

1Yin Shen$9,286,09410 gr2Anusha Murthy Vable$8,994,7083 gr3Julio Cesar Rojas-Martinez$7,570,3031 gr4Michael Clark Oldham$7,077,9324 gr5Tomasz Nowakowski$6,797,9845 gr6Michael R Wilson$6,575,4064 gr7David R Raleigh$6,030,0694 gr8Rahul Aggarwal$5,953,0567 gr

All-Time

Most funded here, all years

1Jon David Levine$38,485,42817 gr2John L. R. Rubenstein$34,665,1089 gr3Hiten D Madhani$33,087,20614 gr4Graeme W Davis$30,172,96717 gr5Arnold Kriegstein$28,892,37115 gr6Daniel B Vigneron$27,396,49515 gr7Davide Ruggero$26,478,45211 gr8David J Julius$26,070,43211 gr

Largest grants

QCRG Pandemic Response Program$67,452,049
U19 · FY2022 · AI
The Alzheimer's Disease Tau Platform Clinical Trial$30,887,229
R01 · FY2023 · AG
The Alzheimer's Disease Tau Platform Clinical Trial$29,813,375
R01 · FY2024 · AG
UCSF Core Center for Patient-centric Mechanistic Phenotyping in Chronic Low Back Pain$29,408,845
U19 · FY2019 · AR
Immune Tolerance Network: Autoimmune Diseases$24,391,895
N01 · FY2008 · AI
Clinical and Translational Science Institute$19,399,499
UL1 · FY2015 · TR
Clinical and Translational Science Institute$19,370,123
UL1 · FY2014 · TR
Clinical and Translational Science Institute$19,007,879
UL1 · FY2007 · RR
Clinical and Translational Science Institute$18,994,467
UL1 · FY2012 · TR
Clinical and Translational Science Institute$18,941,306
UL1 · FY2008 · RR
Clinical and Translational Science Institute$18,848,944
UL1 · FY2009 · RR
Clinical and Translational Science Institute$18,843,751
UL1 · FY2016 · TR
Clinical and Translational Science Institute$18,818,622
UL1 · FY2011 · RR
Clinical and Translational Science Institute$17,959,064
UL1 · FY2010 · RR
Clinical and Translational Science Institute$17,672,486
UL1 · FY2013 · TR
Clinical and Translational Science Institute$17,024,421
UL1 · FY2017 · TR
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP)$15,782,145
R01 · FY2024 · AG
Clinical and Translational Science Institute$14,750,687
UL1 · FY2006 · RR
Immune Tolerance Network: Kidney, Liver and Bone Marrow Transplantation$14,635,137
N01 · FY2008 · AI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$14,579,386
UL1 · FY2007 · RR